Patents by Inventor Jennifer XIONG

Jennifer XIONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240173307
    Abstract: Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.
    Type: Application
    Filed: June 6, 2023
    Publication date: May 30, 2024
    Inventors: Kathleen Ann Martin, Carmela Sidrauski, Marina Pliushchev, Jennifer M. Frost, Yunsong Tong, Xiangdong Xu, Lei Shi, Qingwei Zhang, Zhaoming Xiong, Ramzi Farah Sweis, Michael J. Dart, Kathleen J. Murauski
  • Publication number: 20240166652
    Abstract: Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.
    Type: Application
    Filed: May 26, 2023
    Publication date: May 23, 2024
    Inventors: Kathleen Ann Martin, Carmela Sidrauski, Marina Pliushchev, Jennifer M. Frost, Yunsong Tong, Lawrence A. Black, Xiangdong Xu, Lei Shi, Qingwei Zhang, SeungWon Chung, Zhaoming Xiong, Ramzi Farah Sweis, Michael J. Dart, Brian S. Brown, Kathleen J. Murauski
  • Publication number: 20240024431
    Abstract: A composition for topical administration to an epithelium is disclosed. The composition comprises a deconstructed matrisome including one or more enzymatically fragmented peptides derived from biological tissue. The composition further comprises one or more pharmaceutically acceptable or cosmetically acceptable excipients. The deconstructed matrisome may be fragmented through degradation by one or more enzymes to produce the one or more peptides. The one or more peptides may be configured to retain cell signaling ability, thereby promoting one or more of tissue homeostasis, tissue repair, and tissue regeneration. The composition may be used to treat a tissue such as skin tissue exhibiting scarring, acne, eczema, psoriasis, and other skin conditions.
    Type: Application
    Filed: September 8, 2021
    Publication date: January 25, 2024
    Inventors: John D. O'NEILL, Igal GERMANGUZ, Evelyn ARANDA, Jennifer XIONG, Natalia KISSEL, Alexandra NICHOLS, Eddie GADEE, Richard NGUYEN, Drew DALY, Andrea NYE
  • Publication number: 20220267720
    Abstract: An in vitro cell culture substrate is disclosed. The substrate comprises a decellularized tissue-specific extracellular matrix, wherein the tissue-specific extracellular matrix is derived from fibrotic tissue. A method of method of assessing an in vitro fibrotic cell culture is also disclosed. The method comprises providing one or more substrates comprising decellularized tissue-specific extracellular matrix derived from fibrotic tissue, where each substrate is provided in segregated manner. The method further comprises culturing native cells in each substrate to form a fibrotic cell culture. The method further comprises assessing at least one characteristic of each fibrotic cell culture.
    Type: Application
    Filed: July 23, 2020
    Publication date: August 25, 2022
    Inventors: John O'NEILL, Igal GERMANGUZ, Evelyn ARANDA, Jennifer XIONG, Natalia KISSEL, Alexandra NICHOLS